广州康采恩医药有限公司 CHINA MEDICINE CORP.
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
China Medicine Announces Fourth Quarter and Full Year 2009 Results 2010-03-29 19:40
China Medicine Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Results 2010-03-24 21:48
China Medicine Corporation Applies to List on NASDAQ Global Market 2010-03-10 21:00
China Medicine Corporation Announces Closing of Financing, New Board Member 2010-02-02 21:00
China Medicine Corporation Enters Into a $69.6 Million Financing Agreement with One Equity Partners 2010-01-07 21:00
China Medicine Announces Changes to Management Team 2009-12-23 21:00
China Medicine Announces Strong Third Quarter 2009 Results 2009-11-16 21:00
China Medicine Announces Conference Call to Discuss Third Quarter 2009 Results 2009-11-10 22:00
China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou 2009-10-30 21:00
China Medicine Corporation's Levocarnitine Dried Powder Injection Was Registered with the Ministry of Health of Pakistan 2009-10-20 21:00
China Medicine Enhances Management Team with Appointments of New Chief Financial Officer and Finance Manager 2009-08-31 20:00
China Medicine Announces Second Quarter 2009 Results 2009-08-13 20:00
China Medicine Announces Conference Call to Discuss Second Quarter 2009 Results 2009-08-10 21:48
China Medicine Receives rADTZ Feasibility Report from the Feed Research Institute, Chinese Academy of Agricultural Sciences 2009-07-16 21:00
China Medicine Receives Approval for a RMB 20 Million Loan 2009-07-08 23:19
China Medicine Corporation Holds Annual General Meeting of Shareholders 2009-05-20 21:00
China Medicine Announces First Quarter 2009 Results 2009-05-13 19:00
China Medicine Announces Conference Call to Discuss First Quarter 2009 Results 2009-05-06 20:00
China Medicine to Present at CCG IR’s China Rising Conference in New York 2009-05-05 20:00
China Medicine Corporation Achieves Major Milestone for rADTZ 2009-04-24 20:00
1 2 3 4